Lakefront Biotherapeutics (LKFT) EBIT Growth (1y) (2015 - 2026)
Lakefront Biotherapeutics (LKFT) EBIT Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | 59.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.86% |
| Dec 31, 2025 | 961.99% |
| Sep 30, 2025 | -137.54% |
| Jun 30, 2025 | 54.96% |
| Mar 31, 2025 | -379.03% |
| Dec 31, 2024 | -67.19% |
| Sep 30, 2024 | -1,264.04% |
| Jun 30, 2024 | 851.19% |
| Mar 31, 2024 | -133.35% |
| Dec 31, 2023 | 5,332.50% |
| Sep 30, 2023 | 62.15% |
| Jun 30, 2023 | 82.32% |
| Mar 31, 2023 | 32.86% |
| Dec 31, 2022 | -3.19% |
| Sep 30, 2022 | 78.62% |
| Jun 30, 2022 | -63.32% |
| Mar 31, 2022 | 58.37% |
| Dec 31, 2021 | 102.31% |
| Sep 30, 2021 | -4.77% |
| Jun 30, 2021 | 46.98% |